Offer - Urjas Oil for just ₹ 1 X
Carzec 3.125 Tablet is a prescription drug, available for use as Tablet. Primarily, it is used for the treatment of High BP. Carzec 3.125 Tablet also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Carzec 3.125 Tablet. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Carzec 3.125 Tablet as well, which are listed below. Normally, these side effects of Carzec 3.125 Tablet are not long lasting and go away when the treatment is finished. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Carzec 3.125 Tablet is Moderate for pregnant women and Safe for women who are breastfeeding. It is important to know if Carzec 3.125 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Carzec 3.125 Tablet related warnings section.
Carzec 3.125 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Bradycardia (Slow Heart Rate), Peripheral Vascular Disease (PVD) as it can result in adverse effects. The section on Carzec 3.125 Tablet contraindications lists all such conditions.
Besides this, Carzec 3.125 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Carzec 3.125 Tablet is not safe while driving, and is is not addictive in nature.
Carzec 3.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Carzec 3.125 Tablet safe for pregnant women?
Carzec can have harmful effects in pregnant women. If you experience any discomfort after using Carzec, then discontinue the use and take your doctor's advice.
Is the use of Carzec 3.125 Tablet safe during breastfeeding?
Breastfeeding women can safely use Carzec.
What is the effect of Carzec 3.125 Tablet on the Kidneys?
Using Carzec does not have any harmful effects on kidneys.
What is the effect of Carzec 3.125 Tablet on the Liver?
Carzec may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Carzec 3.125 Tablet on the Heart?
Carzec may have mild side effects on the heart. Most people will never see any effect on the heart.
If you are suffering from any of the following diseases, you should not take Carzec 3.125 Tablet unless your doctor advises you to do so -
Is this Carzec 3.125 Tablet habit forming or addictive?
No, you will not get addicted to Carzec 3.125 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Carzec 3.125 Tablet can make you feel drowsy.
Is it safe?
Yes, but take Carzec 3.125 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Carzec 3.125 Tablet cannot treat any kind of mental disorder.
Interaction between Food and Carzec 3.125 Tablet
Eating certain foods may increase the time it takes Carzec 3.125 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Carzec 3.125 Tablet
Consult your doctor before consuming alcohol while taking Carzec 3.125 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 287-288
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 564
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg® (carvedilol)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Coreg Cr® (carvedilol phosphate)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Vedilol® (carvedilol)